Bulletin
Investor Alert

New York Markets Close in:

UroGen Pharma Ltd.

NAS: URGN

GO
/marketstate/country/us

Market open

/zigman2/quotes/202929873/composite

$

20.31

Change

-0.07 -0.34%

Volume

Volume 99,839

Nov 27, 2020, 12:50 p.m.

Real time quotes

/zigman2/quotes/202929873/composite

Previous close

$ 20.38

$ 20.31

Change

-0.07 -0.34%

Day low

Day high

$19.91

$20.80

Open
Open: 20.22

52 week low

52 week high

$13.12

$35.21

Open

Market cap

$450.26M

Average volume

127,084

P/E ratio

N/A

Rev. per Employee

$104.05

EPS

-6.39

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/urgn

MarketWatch News on URGN

  1. UroGen Pharma stock price target cut to $41 from $61 at Stifel Nicolaus

    7:07 a.m. Oct. 21, 2019

    - Tomi Kilgore

  2. UroGen Pharma stock price target cut to $61 from $63 at Stifel Nicolaus

    8:12 a.m. Aug. 13, 2019

    - Tomi Kilgore

  3. UroGen initiated at neutral at JPMorgan

    7:22 a.m. May 30, 2019

    - Ciara Linnane

  4. UroGen Pharma upgraded to outperform from market perform at Raymond James

    6:58 a.m. April 4, 2018

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/urgn

Other News on URGN

  1. 10-Q: UROGEN PHARMA LTD.

    7:43 a.m. Nov. 9, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. UroGen Pharma trades high; expands executive leadership team

    10:23 a.m. Sept. 9, 2020

    - Seeking Alpha

  3. Oncology Stocks Area Trading Materially Lower The Last 2 Months

    7:00 a.m. Aug. 24, 2020

    - Seeking Alpha

  4. 10-Q: UROGEN PHARMA LTD.

    7:17 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. 10-Q: UROGEN PHARMA LTD.

    6:07 a.m. May 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. UroGen Is A Compelling Value With Recent FDA Approval

    1:50 a.m. April 28, 2020

    - Seeking Alpha

  7. 7 Stocks to Buy for Their Double-Digit Growth Prospects

    10:05 a.m. April 27, 2020

    - InvestorPlace.com

  8. INO, BBBY among premarket gainers

    8:19 a.m. April 16, 2020

    - Seeking Alpha

  9. FDA OKs UroGen's mitomycin gel for rare urothelial cancer

    2:21 p.m. April 15, 2020

    - Seeking Alpha

  10. UroGen (URGN) Looks Good: Stock Adds 8.1% in Session

    7:53 a.m. April 6, 2020

    - Zacks.com

  11. UroGen's UGN-102 shows positive effect ih bladder cancer study

    7:34 a.m. April 3, 2020

    - Seeking Alpha

  12. Stocks To Watch: 0% To The Rescue?

    7:49 a.m. March 14, 2020

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/urgn

Press Releases on URGN

  1. UroGen Pharma Announces November 2020 Conference Schedule

    8:00 a.m. Nov. 10, 2020

    - BusinessWire - BZX

  2. UroGen Pharma Ltd. to Host Earnings Call

    6:33 a.m. Nov. 9, 2020

    - ACCESSWIRE

  3. UroGen Pharma Announces September 2020 Conference Schedule

    7:00 a.m. Sept. 10, 2020

    - BusinessWire - BZX

  4. Non Muscle Invasive Bladder Cancer Pipeline Insight, 2020

    5:42 p.m. July 15, 2020

    - ABNewswire

  5. UroGen Pharma to Present at Jefferies Virtual Healthcare Conference

    7:00 a.m. June 1, 2020

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.